<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT04416256</url>
  </required_header>
  <id_info>
    <org_study_id>COVID/W.W.</org_study_id>
    <nct_id>NCT04416256</nct_id>
  </id_info>
  <brief_title>COVID-19 Pandemic and Worldwide Organ Procurement</brief_title>
  <acronym>COVID</acronym>
  <official_title>Consequences of the COVID-19 Pandemic on Worldwide Organ Procurement and Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paris Translational Research Center for Organ Transplantation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agence de La Biomédecine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eurotransplant</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United Network for Organ Sharing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Stiftung Organtransplantation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Nazionale Trapianti</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brazilian Organ Transplant Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Canadian Association of Transplantation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Scandiatransplant</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nederlandse Transplantatie Vereniging</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Austrotransplant</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Nacional de Trasplantes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Nacional de Donación y Trasplante de Células, Tejidos y Órganos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Donor Network of Croatia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Nacional Central Único Coordinador de Ablación e Implante</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Corporación Nacional de Trasplantes de Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Australian Organ and Tissue Donation and Transplantation Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Organización Nacional de Trasplantes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Autoridade Para Services de Sangue e Transplantacáo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Paris Translational Research Center for Organ Transplantation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      End-stage organ failure is estimated to affect more than 4 to 6 million persons worldwide. In&#xD;
      2018, transplant systems across the globe enabled around 150,000 patients to benefit from a&#xD;
      kidney, heart, lung, liver, or other solid organ, a number that was far less than the demand.&#xD;
      According to data from the World Health Organization, more than 1,500,000 persons live with a&#xD;
      transplanted organ worldwide. In the US, approximately 40,000 patients receive an organ&#xD;
      transplant every year, but 120,000 still remain waitlisted for transplantation today, with&#xD;
      7,600 dying annually while waiting for an organ transplant. A similar lack of organs and high&#xD;
      death rates on the waiting list affect patients in Europe and many other countries.&#xD;
&#xD;
      As nations adjust to new realities driven by the coronavirus (COVID-19) outbreak, many health&#xD;
      care providers, institutions and patients are concerned about the potential impact that&#xD;
      COVID-19 will have on organ donation and transplantation. One concern is that transplant&#xD;
      recipients may have a greater susceptibility to infection and greater viral burden. A second&#xD;
      concern is that hospitals will lack the resources in terms of staff and equipment to care for&#xD;
      recipients after transplantation, who often require intensive care and multispecialty&#xD;
      management.&#xD;
&#xD;
      Because of the overwhelming healthcare system burden, a dramatic negative effect on worldwide&#xD;
      organ donation and transplantation is anticipated, but has not been measured. Our objective&#xD;
      was to quantify the worldwide impact of COVID-19 pandemic on organ donation and&#xD;
      transplantation and consequences for waitlisted patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Organ transplantation activity during COVID-19 pandemic</measure>
    <time_frame>Two years since COVID-19 outbreak.</time_frame>
    <description>Overall deceased donor transplantation performed during the COVID-19 pandemic. Stratified analysis by deceased donor type (Kidney, lung, Liver, heart), and combined transplantations during the COVID-19 pandemic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Further analysis on organ transplantation with stratification</measure>
    <time_frame>Two years since COVID-19 outbreak.</time_frame>
    <description>Geographic disparities related to organ transplantation rates and association with COVID-19 clusters Living donor transplantation performed during the COVID-19 pandemic. Quality of transplanted organs (kidney) before and after the COVID-19 pandemic. Change in relationship between living donors and their recipients before and after the COVID-19 pandemic.</description>
  </secondary_outcome>
  <number_of_groups>18</number_of_groups>
  <enrollment type="Anticipated">230000</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>France</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spain</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Portugal</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Croatia</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Germany</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Italy</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Netherlands</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Austria</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Canada</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mexico</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brazil</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Uruguay</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Argentina</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chile</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Australia</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Belgium</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Finland</arm_group_label>
    <description>All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Solid organ transplants performed during the study period (kidney, lung, heart, liver and&#xD;
        combined organs in Europe (France, Spain, Portugal, Germany, Italy, Croatia, Belgium,&#xD;
        Netherlands, Austria), North America (US and Canada), Central and South America (Mexico,&#xD;
        Brazil, Uruguay, Argentina and Chile) and Oceania (Australia)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All organs procured for transplantation and transplanted during the observation&#xD;
             period. These include kidney, lung, liver, heart, and combined transplantations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Loupy</last_name>
    <role>Principal Investigator</role>
    <affiliation>Paris Translational Research Center for Organ Transplantation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandre Loupy</last_name>
    <phone>+33 1 53 98 80 00</phone>
    <email>alexandre.loupy@inserm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Paris Transplant Group</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre Loupy</last_name>
      <phone>+33 1 53 98 80 00</phone>
      <email>alexandre.loupy@inserm.fr</email>
    </contact>
    <investigator>
      <last_name>Alexandre Loupy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carmen Lefaucheur, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier Aubert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Xu B, Kraemer MUG; Open COVID-19 Data Curation Group. Open access epidemiological data from the COVID-19 outbreak. Lancet Infect Dis. 2020 May;20(5):534. doi: 10.1016/S1473-3099(20)30119-5. Epub 2020 Feb 19. No abstract available.</citation>
    <PMID>32087115</PMID>
  </reference>
  <reference>
    <citation>Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020 Mar 21;395(10228):931-934. doi: 10.1016/S0140-6736(20)30567-5. Epub 2020 Mar 9. No abstract available.</citation>
    <PMID>32164834</PMID>
  </reference>
  <reference>
    <citation>Ahn C, Amer H, Anglicheau D, Ascher NL, Baan CC, Battsetset G, Bat-Ireedui B, Berney T, Betjes MGH, Bichu S, Birn H, Brennan D, Bromberg J, Caillard S, Cannon RM, Cantarovich M, Chan A, Chen ZS, Chapman JR, Cole EH, Cross N, Durand F, Egawa H, Emond JC, Farrero M, Friend PJ, Geissler EK, Ha J, Haberal MA, Henderson ML, Hesselink DA, Humar A, Jassem W, Jeong JC, Kaplan B, Kee T, Kim SJ, Kumar D, Legendre CM, Man K, Moulin B, Muller E, Munkhbat R, Od-Erdene L, Perrin P, Rela M, Tanabe K, Tedesco Silva H, Tinckam KT, Tullius SG, Wong G. Global Transplantation COVID Report March 2020. Transplantation. 2020 Oct;104(10):1974-1983. doi: 10.1097/TP.0000000000003258. No abstract available.</citation>
    <PMID>32243281</PMID>
  </reference>
  <reference>
    <citation>Zhang X. Epidemiology of Covid-19. N Engl J Med. 2020 May 7;382(19):1869. doi: 10.1056/NEJMc2005157. Epub 2020 Mar 27. No abstract available.</citation>
    <PMID>32220200</PMID>
  </reference>
  <reference>
    <citation>Martino F, Plebani M, Ronco C. Kidney transplant programmes during the COVID-19 pandemic. Lancet Respir Med. 2020 May;8(5):e39. doi: 10.1016/S2213-2600(20)30182-X. Epub 2020 Apr 16. No abstract available.</citation>
    <PMID>32305079</PMID>
  </reference>
  <reference>
    <citation>Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, Ross M, Forest S, Goldstein YD, Ajaimy M, Liriano-Ward L, Pynadath C, Loarte-Campos P, Nandigam PB, Graham J, Le M, Rocca J, Kinkhabwala M. Covid-19 and Kidney Transplantation. N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24. No abstract available.</citation>
    <PMID>32329975</PMID>
  </reference>
  <reference>
    <citation>Coates PT, Wong G, Drueke T, Rovin B, Ronco P; Associate Editors, for the Entire Editorial Team. Early experience with COVID-19 in kidney transplantation. Kidney Int. 2020 Jun;97(6):1074-1075. doi: 10.1016/j.kint.2020.04.001. Epub 2020 Apr 9. No abstract available.</citation>
    <PMID>32354635</PMID>
  </reference>
  <reference>
    <citation>Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344. No abstract available.</citation>
    <PMID>32181795</PMID>
  </reference>
  <reference>
    <citation>Omer SB, Malani P, Del Rio C. The COVID-19 Pandemic in the US: A Clinical Update. JAMA. 2020 May 12;323(18):1767-1768. doi: 10.1001/jama.2020.5788. No abstract available.</citation>
    <PMID>32250388</PMID>
  </reference>
  <reference>
    <citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19. No abstract available. Erratum In: Lancet Infect Dis. 2020 Sep;20(9):e215.</citation>
    <PMID>32087114</PMID>
  </reference>
  <results_reference>
    <citation>Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M, Kasiske B, Kottgen A, Kretzler M, Levey AS, Luyckx VA, Mehta R, Moe O, Obrador G, Pannu N, Parikh CR, Perkovic V, Pollock C, Stenvinkel P, Tuttle KR, Wheeler DC, Eckardt KU; ISN Global Kidney Health Summit participants. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017 Oct 21;390(10105):1888-1917. doi: 10.1016/S0140-6736(17)30788-2. Epub 2017 Apr 20.</citation>
    <PMID>28434650</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 29, 2020</study_first_submitted>
  <study_first_submitted_qc>June 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>organ</keyword>
  <keyword>procurement</keyword>
  <keyword>transplantation</keyword>
  <keyword>pandemic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT04416256
org study id: COVID/W.W.
nct id: NCT04416256
lead sponsor: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
is fda regulated drug: No
is fda regulated device: No
End-stage organ failure is estimated to affect more than 4 to 6 million persons worldwide. In
      2018, transplant systems across the globe enabled around 150,000 patients to benefit from a
      kidney, heart, lung, liver, or other solid organ, a number that was far less than the demand.
      According to data from the World Health Organization, more than 1,500,000 persons live with a
      transplanted organ worldwide. In the US, approximately 40,000 patients receive an organ
      transplant every year, but 120,000 still remain waitlisted for transplantation today, with
      7,600 dying annually while waiting for an organ transplant. A similar lack of organs and high
      death rates on the waiting list affect patients in Europe and many other countries.

      As nations adjust to new realities driven by the coronavirus (COVID-19) outbreak, many health
      care providers, institutions and patients are concerned about the potential impact that
      COVID-19 will have on organ donation and transplantation. One concern is that transplant
      recipients may have a greater susceptibility to infection and greater viral burden. A second
      concern is that hospitals will lack the resources in terms of staff and equipment to care for
      recipients after transplantation, who often require intensive care and multispecialty
      management.

      Because of the overwhelming healthcare system burden, a dramatic negative effect on worldwide
      organ donation and transplantation is anticipated, but has not been measured. Our objective
      was to quantify the worldwide impact of COVID-19 pandemic on organ donation and
      transplantation and consequences for waitlisted patients.
observational model: Cohort
time perspective: Prospective
measure: Organ transplantation activity during COVID-19 pandemic
time frame: Two years since COVID-19 outbreak.
description: Overall deceased donor transplantation performed during the COVID-19 pandemic. Stratified analysis by deceased donor type (Kidney, lung, Liver, heart), and combined transplantations during the COVID-19 pandemic.
measure: Further analysis on organ transplantation with stratification
time frame: Two years since COVID-19 outbreak.
description: Geographic disparities related to organ transplantation rates and association with COVID-19 clusters Living donor transplantation performed during the COVID-19 pandemic. Quality of transplanted organs (kidney) before and after the COVID-19 pandemic. Change in relationship between living donors and their recipients before and after the COVID-19 pandemic.
arm group label: France
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Spain
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Portugal
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Croatia
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Germany
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Italy
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Netherlands
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Austria
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: US
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Canada
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Mexico
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Brazil
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Uruguay
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Argentina
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Chile
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Australia
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Belgium
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
arm group label: Finland
description: All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
study pop: 
sampling method: Non-Probability Sample
criteria: 
gender: All
minimum age: N/A
maximum age: N/A
healthy volunteers: No
last name: Alexandre Loupy
role: Principal Investigator
affiliation: Paris Translational Research Center for Organ Transplantation
last name: Alexandre Loupy
phone: +33 1 53 98 80 00
email: alexandre.loupy@inserm.fr
facility: 
status: Recruiting
contact: 
investigator: 
investigator: 
investigator: 
country: France
citation: Xu B, Kraemer MUG; Open COVID-19 Data Curation Group. Open access epidemiological data from the COVID-19 outbreak. Lancet Infect Dis. 2020 May;20(5):534. doi: 10.1016/S1473-3099(20)30119-5. Epub 2020 Feb 19. No abstract available.
PMID: 32087115
citation: Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020 Mar 21;395(10228):931-934. doi: 10.1016/S0140-6736(20)30567-5. Epub 2020 Mar 9. No abstract available.
PMID: 32164834
citation: Ahn C, Amer H, Anglicheau D, Ascher NL, Baan CC, Battsetset G, Bat-Ireedui B, Berney T, Betjes MGH, Bichu S, Birn H, Brennan D, Bromberg J, Caillard S, Cannon RM, Cantarovich M, Chan A, Chen ZS, Chapman JR, Cole EH, Cross N, Durand F, Egawa H, Emond JC, Farrero M, Friend PJ, Geissler EK, Ha J, Haberal MA, Henderson ML, Hesselink DA, Humar A, Jassem W, Jeong JC, Kaplan B, Kee T, Kim SJ, Kumar D, Legendre CM, Man K, Moulin B, Muller E, Munkhbat R, Od-Erdene L, Perrin P, Rela M, Tanabe K, Tedesco Silva H, Tinckam KT, Tullius SG, Wong G. Global Transplantation COVID Report March 2020. Transplantation. 2020 Oct;104(10):1974-1983. doi: 10.1097/TP.0000000000003258. No abstract available.
PMID: 32243281
citation: Zhang X. Epidemiology of Covid-19. N Engl J Med. 2020 May 7;382(19):1869. doi: 10.1056/NEJMc2005157. Epub 2020 Mar 27. No abstract available.
PMID: 32220200
citation: Martino F, Plebani M, Ronco C. Kidney transplant programmes during the COVID-19 pandemic. Lancet Respir Med. 2020 May;8(5):e39. doi: 10.1016/S2213-2600(20)30182-X. Epub 2020 Apr 16. No abstract available.
PMID: 32305079
citation: Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, Ross M, Forest S, Goldstein YD, Ajaimy M, Liriano-Ward L, Pynadath C, Loarte-Campos P, Nandigam PB, Graham J, Le M, Rocca J, Kinkhabwala M. Covid-19 and Kidney Transplantation. N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24. No abstract available.
PMID: 32329975
citation: Coates PT, Wong G, Drueke T, Rovin B, Ronco P; Associate Editors, for the Entire Editorial Team. Early experience with COVID-19 in kidney transplantation. Kidney Int. 2020 Jun;97(6):1074-1075. doi: 10.1016/j.kint.2020.04.001. Epub 2020 Apr 9. No abstract available.
PMID: 32354635
citation: Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344. No abstract available.
PMID: 32181795
citation: Omer SB, Malani P, Del Rio C. The COVID-19 Pandemic in the US: A Clinical Update. JAMA. 2020 May 12;323(18):1767-1768. doi: 10.1001/jama.2020.5788. No abstract available.
PMID: 32250388
citation: Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19. No abstract available. Erratum In: Lancet Infect Dis. 2020 Sep;20(9):e215.
PMID: 32087114
citation: Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M, Kasiske B, Kottgen A, Kretzler M, Levey AS, Luyckx VA, Mehta R, Moe O, Obrador G, Pannu N, Parikh CR, Perkovic V, Pollock C, Stenvinkel P, Tuttle KR, Wheeler DC, Eckardt KU; ISN Global Kidney Health Summit participants. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017 Oct 21;390(10105):1888-1917. doi: 10.1016/S0140-6736(17)30788-2. Epub 2017 Apr 20.
PMID: 28434650
responsible party type: Sponsor
mesh term: COVID-19
sharing ipd: No